Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Casi Pharmaceuticals Inc.
Headquarters: Rockville, MD, United States of America
Website: http://www.casipharmaceutic...
Year Founded: 1991
Status: Public
Industry Sector: HealthTechnology
CEO: Wei Wu He, PhD, MBA
Number Of Employees: 233
Enterprise Value: $49,462,984
PE Ratio: -0.77
Exchange/Ticker 1: NASDAQ:CASI
Exchange/Ticker 2: N/A
Latest Market Cap: $28,478,000
BioCentury | Apr 1, 2022
Finance
March 31 Quick Takes: V-Bio, HealthQuad close venture funds
Plus CDMO Abzena raises $65M, Clovis meets in ovarian cancer, InflaRx misses in COVID, FDA updates COVID EUA guidance and more
BioCentury | Dec 3, 2021
Management Tracks
Sniecinski becomes CBO at Praxis
Plus: Monte Rosa, Taro, Point, Harbour and more
BioCentury | Oct 26, 2021
Product Development
Oct. 25 Quick Takes: FDA approves Bausch + Lomb’s Xipere
Plus AstraZeneca, AnaptysBio, Novartis, Sanofi and more
BioCentury | Aug 20, 2021
Management Tracks
Actelion takeout, COVID-19 vaccine among Gorsky’s J&J highlights as he readies to hand CEO job to Duato
Plus: BlueSphere, MAIA, Solid, Decibel, Corbus
BioCentury | Apr 2, 2021
Management Tracks
BeiGene unveils new CFO; plus Precigen, Alphamab, Flagship, Melinta, Immunome and more
BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) promoted SVP Julia Wang to CFO, effective June 30. Wang, who joined BeiGene last June, has held leadership roles in finance at Alexion Pharmaceuticals Inc.
BioCentury | Mar 27, 2021
Management Tracks
Amgen’s Martin to succeed Lee as Gilead’s EVP of research; plus Medicxi, Bavarian Nordic, Antengene, Arcutis and CASI
Gilead Sciences Inc. (NASDAQ:GILD) hired Amgen Inc. (NASDAQ:AMGN) vet Flavius Martin as EVP of research to succeed William Lee, who is retiring after a 30-year tenure with the big biotech.
BioCentury | Dec 21, 2020
Management Tracks
CFO transitions at Translate, Spero, Ziopharm, Precision, CASI, Tessa, Kiniksa and Aquestive; plus updates from 3T, Novavax, Alnylam and more
mRNA company Translate Bio Inc. (NASDAQ:TBIO) announced John Schroer will step down as CFO at year-end. VP and corporate controller Robert Prentiss will serve as principal accounting officer on an
BioCentury | Oct 30, 2020
Finance
Oct. 29 Quick Takes: Ultragenyx, Scholar Rock, Galecto, Citrine-Bioprojet, miRagen-Viridian, Elpis, CASI-BioInvent
Ultragenyx, Scholar Rock offerings Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Scholar Rock Holding Corp. (NASDAQ:SRRK) raised follow-ons late Wednesday. Ultragenyx raised $400
BioCentury | Sep 19, 2019
Company News
Management tracks: CASI promotes Zhang to president; plus Five Prime, Black Diamond, Oyster Point, Enyo, X4, Nimbus and Canbridge
BioCentury | Jun 19, 2019
Company News
June 19 Company Quick Takes: Catalent takes over manufacturing site from BMS; plus Lynparza, Myriad, Amgen and more
Items per page:
1 - 10 of 28